The abstract is read at the publisher; the summary is JClub's.
CHAMP flow cytometry showed that cytosolic accumulation of 40 cell-penetrating peptides varies widely in mammalian cells, and none had greater apparent accumulation in mammalian cells than in Escherichia coli.
- Why it matters: Cytosolic delivery is a key bottleneck for antibacterial therapy, and fluorescence uptake assays can confuse surface association with true cytosolic arrival.
- What they did: The study used the CHAMP assay, a HaloTag-based flow cytometry method, to directly quantify cytosolic arrival of 40 CPPs in mammalian cells and Escherichia coli.
- The result: Complementary tests indicated some CPPs reached the bacterial cytosol without detectable membrane damage, while others accumulated with compromised membrane integrity, enabling a framework for selecting CPP carriers for antibiotic conjugates.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.